The University of Florida will attempt to vaccinate more than 1,000 students as part of a landmark national study to determine whether young people who have received a COVID-19 vaccine can still spread the coronavirus.
New research published in Science looks back at how COVID-19 spread over time throughout Brazil, to create a pandemic hotspot.
ntists can grow individual cell lines in a dish and study how the coronavirus infects them. And that’s useful as far as it goes. In a sense, however, it’s like studying how a car works by looking at just the carburetor. To gain the most insight, researchers want to study human lung tissue in its full, multidimensional glory, with all cell types represented.
Cindy Prins, Ph.D., offers infection control assessments for UF entities who aim to resume activities throughout campus.
Members in UF’s Warren B. Nelms Institute, CISE and ECE are developing an affordable wearable device that indicates appropriate social distancing.
Infectious disease modeler and biostatistician Ira Longini is applying decades of experience to help design and analyze clinical trials to identify a safe and effective COVID-19 vaccine.
The trial is part of the national HERO Registry centered on COVID-19 investigations.
Despite more than 450,000 deaths from COVID-19 so far in the U.S., nearly a third of Americans say they definitely or probably will not get the vaccine, according to a recent Associated Press-NORC Center for Public Affairs survey.
Coronaviruses common to animals may ‘spillover’ into people more frequently than once thought, according to new research from UF and Haitian investigators.
UF CJC today announced it has received a $30,000 grant from Lumina Foundation to study the financial state of college newspapers during COVID-19.
Choices are affected by how people see the world, whom they trust, their perceptions of risk and consistency of message.
The race to find effective treatments for COVID-19 isn’t just about developing new drugs. University of Florida Health scientists are studying a trio of existing medications known to have broad antiviral activity.